Filter Results:
(4,892)
Show Results For
- All HBS Web
(4,892)
- People (17)
- News (1,938)
- Research (2,368)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,858)
Show Results For
- All HBS Web
(4,892)
- People (17)
- News (1,938)
- Research (2,368)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,858)
- 29 Aug 2016
- News
Health Insurers’ Pullback Threatens to Create Monopolies
- 01 May 2008
- News
Interview: Does Our Health System Deliver Value?
- 01 Jan 2008
- News
Value-based Health Care: The MD Anderson Experience
- 18 Oct 2016
- News
Why Business Should Invest in Community Health
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
- Web
Health Business Fulltext Elite | Baker Library
Health Business Fulltext Elite Journal articles on all non-clinical aspects of health care management. Read More Includes aspects of health View Details
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
RIPPLE EFFECT “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” For 15 years, the morning-after... View Details
- 06 Feb 2007
- News
Universal Health Care: A New Business Paradigm?
- 05 Sep 2013
- News
Who Will Radically Disrupt American Health Care?
- June 2014 (Revised April 2015)
- Supplement
OrthoChoice: Bundled Payments in the County of Stockholm (B)
By: Michael E. Porter, Clifford M. Marks and Zachary C. Landman
By the end of 2008, all major hospitals (one of which was private) and three private specialized orthopedic centers signed OrthoChoice contracts. In 2009, hip and knee replacements in the County of Stockholm for relatively healthy patients began being reimbursed. By... View Details
Keywords: Hip Replacement; Bundled Payment; Knee Replacement; Value Agenda; Strategy; Health Care Industry; Health; Health Care and Treatment; Health Disorders; Health Industry; Sweden
Porter, Michael E., Clifford M. Marks, and Zachary C. Landman. "OrthoChoice: Bundled Payments in the County of Stockholm (B)." Harvard Business School Supplement 714-515, June 2014. (Revised April 2015.)
- May 2007 (Revised July 2011)
- Teaching Note
The West German Headache Center: Integrated Migraine Care (TN)
By: Michael E. Porter, Clemens Guth and Elisa M. Dannemiller
Teaching note to 707-559. View Details
- January 1978
- Case
Zero-Base Budgeting in the Public Health Service
Herzlinger, Regina E. "Zero-Base Budgeting in the Public Health Service." Harvard Business School Case 178-080, January 1978.
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- June 2013
- Teaching Note
Boston Children's Hospital: Measuring Patient Costs
By: Robert S. Kaplan
- September 2013
- Supplement
John G. Meara, Boston Children's Hospital, Measuring Costs, TDABC
By: Robert S. Kaplan
Keywords: Health Care; Time-Driven Activity-Based Costing; Costing; Hospitals; Activity Based Costing and Management
Kaplan, Robert S. "John G. Meara, Boston Children's Hospital, Measuring Costs, TDABC." Harvard Business School Video Supplement 114-702, September 2013.
- November 2012 (Revised June 2014)
- Case
Boston Children's Hospital: Measuring Patient Costs (V)
By: Robert S. Kaplan, Mary L. Witkowski and Jessica A. Hohman
Keywords: Health Care; Time-Driven Activity-Based Costing; Costing; Hospitals; Activity Based Costing and Management
Kaplan, Robert S., Mary L. Witkowski, and Jessica A. Hohman. "Boston Children's Hospital: Measuring Patient Costs (V)." Harvard Business School Case 113-057, November 2012. (Revised June 2014.)
- January 2017
- Case
Kada Orthopedics: A Bone of Contention
By: Kevin Schulman and Matt Strickland
Kada Orthopedics is a small implantable orthopedic device manufacturer founded by industry veterans trying to sell stable-technology products to an increasingly cost-conscious healthcare market. Although they have marginally successful product in early 2016, the... View Details
- 2023
- Working Paper
Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?
By: Katherine Baicker, Amitabh Chandra and Mark Shepard
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We suggest that incremental insurance expansions focused on addressing market failures will propagate inefficiencies and... View Details
Baicker, Katherine, Amitabh Chandra, and Mark Shepard. "Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?" NBER Working Paper Series, No. 30854, January 2023.
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)